glp 1 agonist and dpp 4 inhibitor Glucagon-like peptide-1 can you take a dpp4

Drug Targets 8 , 325331 (2007)

In the current investigation, we specifically implemented the Reporting Odds Ratio (ROR) methodology to detect adverse reaction signals, utilizing both the System Organ Class (SOC) and Preferred Term (PT) classifications for the target pharmacological agents

doi: 10.3390/ijms22031273 [DOI] [PMC free article] [PubMed] [Google Scholar] 41

While liraglutide improved spatial cognition, it also reduced astrocytes and microglia activity, ameliorated amount of A levels and mitochondrial dysfunction in cortical and hippocampal CA1 and CA3 regions, and prevented neuron loss by activating cAMP/PKA pathway in brain of 5FAD mice (188, 208)

131 The direct impact of GLP-1 on these cells slows the secretion of glucagon, essential for maintaining glucose stability, especially postprandially

- Third-party tested for quality & purity